Dengue virus structural differences that correlate with pathogenesis

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 4738-4747

  Leitmeyer, Katrin C ^a   Vaughn, David W ^b   Watts, Douglas M ^f   Salas, Rosalba ^c   De Chacon, Iris Villalobos ^d   Ramos, Celso ^e   Rico Hesse, Rebeca ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Instituto Nacional de Higiene Rafael Rangel   (Venezuela)

^d Hospital Central de Maracay   (Venezuela)

^e INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; DENGUE; DENGUE VIRUS; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS INFECTION;

EID: 0033052643     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.4738-4747.1999     Document Type: Article

References (75)

1. Andino, R., G. E. Rieckhof, P. L. Achacoso, and D. Baltimore. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′ end of the viral RNA. Cell 12:3587-3598.
2. Berzofsky, J. A. 1985. Intrinsic and extrinsic factors in protein antigenic structure. Science 229:932-940.
3. Blok, J., A. J. Gibbs, S. M. McWilliam, and U. T. Vitarana. 1991. NS1 gene sequences from eight dengue-2 viruses and their evolutionary relationships with other dengue-2 viruses. Arch. Virol. 118:209-223.
4. Bray, M., and C.-J. Lai. 1991. Dengue virus premembrane and membrane proteins elicit a protective immune response. Virology 185:505-508.
5. Brinton, M. A., and J. H. Dispoto. 1988. Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNA. Virology 162: 290-299.
6. Cahour, A., A. Pletnev, M. Vazeille-Falcoz, L. Rosen, and C.-J. Lai. 1995. Growth-restricted dengue virus mutants containing deletions in the 5′ non-coding region of the RNA genome. Virology 207:68-76.
7. Cecilia, D., and E. A. Gould. 1991. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181:70-77.
8. Chambers, T. J., S. H. Chang, R. Galler, and C. M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44:649-688.
9. Chen, Y., T. Maguire, and R. M. Marks. 1996. Demonstration of binding of dengue virus envelope protein to target cells. J. Virol. 70:8765-8772.
10. Chou, P. Y., and G. D. Fasman. 1978. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 45:45-148.
11. Chungue, E. 1997. Molecular epidemiology of dengue viruses, p. 93-101. In J. F. Saluzzo and B. Dodet (ed.), Factors in the emergence of arbovirus diseases. Elsevier, Paris, France.
12. Day, S. P., P. Murphy, E. A. Brown, and S. M. Lemon. 1992. Mutations within the 5′ nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J. Virol. 66:6533-6540.
13. Evans, D. M. A., G. Dunn, P. D. Minor, G. C. Schild, A. J. Cann, G. Stanway, J. W. Almond, K. Currey, and J. V. J. Maizel. 1985. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314:448-550.
14. Falgout, B., R. Chanock, and C.-J. Lai. 1989. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J. Virol. 63:1852-1860.
15. Felsenstein, J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791.
16. Finney, D. J. 1971. Probit analysis. Cambridge University Press, Cambridge, United Kingdom.
17. Fromm, J. R., R. E. Hileman, E. E. Caldwell, J. M. Weiler, and R. J. Linhardt. 1995. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch. Biochem. Biophys. 323:279-287.
18. Fu, J., B. H. Tan, E. H. Yap, Y. C. Chan, and Y. H. Tan. 1992. Full-length cDNA sequence of dengue type 1 virus (Singapore strain S275/90). Virology 188:935-958.
19. Garnier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accuracy and implications of simple method for predicting the secondary structure of globular proteins. J. Mol. Biol. 120:97-120.
20. Gilbert, D. G. 9 April 1997, posting date. [Online.] loopDloop in Java, a Java application for visualizing RNA secondary structure, v.2.07b. ftp://iubio-.bio.indiana.edu/molbio/loopdloop/java/. [2 April 1999, last date accessed.]
21. Grange, T., M. Bouloy, and M. Girard. 1985. Stable secondary structures at the 3′-end of the genome of yellow fever virus (17D vaccine strain). FEBS Lett. 188:159-163.
22. Gultyaev, A. P., F. H. D. van Batenburg, and C. W. A. Pleij. 1995. The computer simulation of RNA folding pathways using a genetic algorithm. J. Mol. Biol. 250:37-51.
23. Hahn, C. S., Y. S. Hahn, C. M. Rice, E. Lee, L. Dalgarno, E. G. Strauss, and J. H. Strauss. 1987. Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J. Mol. Biol. 198:33-41.
24. Halstead, S. B. 1997. Epidemiology of dengue and dengue hemorrhagic fever, p. 23-44. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, Wallingford, United Kingdom.
25. Halstead, S. B. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 42:350-362.
26. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
27. Hasegawa, H., M. Yoshida, T. Shiosaka, S. Fujita, and Y. Kobayashi. 1992. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 191:158-165.
28. Hofacker, I. L., W. Fontana, P. F. Stadler, S. Bonhoeffer, M. Tacker, and P. Schuster. 1994. Fast folding and comparison of RNA secondary structures. Monatsh. Chem. 125:167-188.
29. Holzmann, H., F. X. Heinz, C. W. Mandl, F. Guirakhoo, and C. Kunz. 1990. A single amino acid substitution in envelope protein E of tick-borne enceph-alitis virus leads to attenuation in the mouse model. J. Virol. 64:5156-5159.
30. Hopp, T. P., and K. R. Woods. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78:3824-3828.
31. Iizuka, N., M. Kohara, K. Hagino-Yamagishi, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Construction of less neurovirulent polioviruses by introducing deletions into the 5′ noncoding sequence of the genome. J. Virol. 63:5354-5363.
32. Jameson, B. A., and H. Wolf. 1988. The antigenic index: a novel algorithm for predicting antigenic determinants. CABIOS 4:181-186.
33. Jennings, A. D., J. E. Whitby, P. D. Minor, and A. D. T. Barrett. 1993. Comparison of the nucleotide and deduced amino acid sequences of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine derived from it. Virology 192:692-695.
34. Jiang, W. R., A. Lowe, S. Higgs, S. Reid, and E. A. Gould. 1993. Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J. Gen. Virol. 74:931-935.
35. Kalayanarooj, S., D. W. Vaughn, S. Nimmannitya, S. Green, S. Suntayakorn, N. Kunentrasai, W. Viramitrachai, S. Ratanachu-eke, S. Kiatpolpoj, B. L. Innis, A. L. Rothmann, A. Nisalak, and F. A. Ennis. 1997. Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis. 176:313-321.
36. Kaufman, B. M., P. L. Summers, D. R. Dubois, W. Houston Cohen, M. K. Gentry, R. L. Timchak, D. S. Burke, and K. H. Eckels. 1989. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 41:575-580.
37. Kinney, R. M., G.-J. Chang, K. R. Tsuchiya, J. M. Sneider, J. T. Roehrig, T. M. Woodward, and D. W. Trent 1993. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5′-noncoding region and the E2 envelope glycoprotein. J. Virol. 67:1269-1277.
38. Kinney, R. M., S. Butrapet, G.-J. J. Chang, K. R. Tsuchiya, J. T. Roehrig, N. Bhamarapravati, and D. Gubler. 1997. Construction of infectious cDNA clones for Dengue 2 virus: strain 16681 and its attenuated vaccine derivate, strain PDK-53. Virology 230:300-308.
39. Kliks, S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444-451.
40. Koonin, E. V. 1993. Computer-assisted identification of a putative methyl-transferase domain in NS5 protein of flaviviruses and gamma 2 protein of reovirus. J. Gen. Virol. 74:733-740.
41. Kurane, I., A. Rothman, P. Livingston, S. Green, S. Gagnon, J. Janus, B. Innis, S. Nimmannitya, A. Nisalak, and F. Ennis. 1994. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 9:59-64.
42. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
43. Lobigs, M., C. E. Arthur, A. Mullbacher, and R. V. Blanden. 1994. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 202:195-201.
44. Lobigs, M., R. Usha, A. Nestorowicz, I. D. Marshall, R. C. Weir, and L. Dalgarno. 1990. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 176:587-595.
45. MacAdam, A. J., G. Ferguson, J. B. D. Stone, R. Skuce, and J. W. Almond. 1992. Correlation of RNA secondary structure and attenuation of Sabin vaccine of poliovirus in tissue culture. Virology 189:415-422.
46. Mandl. C. W., F. Guirakhoo, H. Holzmann, F. X. Heinz, and C. Kunz. 1989. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J. Virol. 63:564-571.
47. Mandl, C. W., F. X. Heinz, and C. Kunz. 1988. Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology 166:197-205.
48. Mangada, M. N., and A. Igarashi. 1997. Sequences of terminal non-coding regions from four dengue-2 viruses isolated from patients exhibiting different disease severities. Virus Genes 14:5-12.
49. Mangada, M. N. M., and A Igarashi. 1998. Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities. Virology 244:458-466.
50. Men, R., M. Bray, D. Clark, R. M. Chanock, and C.-J. Lai. 1996. Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J. Virol. 70:3930-3937.
51. Niesters, H. G. M., and J. H. Strauss. 1990. Defined mutations in the 5′ nontranslated sequence of Sindbis virus RNA. J. Virol. 64:4162-4168.
52. Osatomi, K., and H. Sumiyoshi. 1990. Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176:643-647.
53. Pletnev, A. G., M. Bray, and C.-J. Lai. 1993. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J. Virol. 67:4956-4963.
54. Preugschat, F., E. M. Lenches, and J. H. Strauss. 1991. Flavivirus enzyme-substrate interactions studied with chimeric proteinases: identification of an intragenic locus important for substrate recognition. J. Virol. 65:4749-4758.
55. Proutski, V., M. W. Gaunt, E. A. Gould, and E. C. Holmes. 1997. Secondary structure of the 3′-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J. Gen. Virol. 78:1543-1549.
56. Rauscher, S., C. Flamm, C. W. Mandl, F. X. Heinz, and P. F. Stadler. 1997. Secondary structure of the 3′-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA 3:779-791.
57. Rey, F. A., F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375:291-298.
58. Rico-Hesse, R. 1990. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174:479-493.
59. Rico-Hesse, R., L. Harrison, A. Nisalak, D. Vaughn, S. Kalayanarooj, S. Green, A. Rothman, and F. Ennis. 1998. Molecular evolution of dengue type 2 virus in Thailand. Am. J. Trop. Med. Hyg. 58:96-101.
60. Rico-Hesse, R., L. Harrison, R. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. R. de Mesa, R. Nogueira, and A. Travassos da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244-251.
61. Roehrig, J. T., R. A. Bolin, and R. G. Kelly. 1998. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317-328.
62. Rosen, L. 1977. "The Emperor's New Clothes" revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 26:337-343.
63. Sanchez, I. J., and B. H. Ruiz. 1996. A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J. Gen. Virol. 77:2541-2545.
64. Shapiro, B. A., and K. Zhang. 1990. Comparing multiple RNA secondary structures using tree comparison. CABIOS 6:309-318.
65. Shi, P.-Y., M. A. Brinton, J. M. Veal, Y. Y. Zhong, and W. D. Wilson. 1996. Evidence for the existence of a pseudoknot structure at the 3′ terminus of the flavivirus genomic RNA. Biochemistry 35:4222-4230.
66. Sumiyoshi, H., G. H. Tignor, and R. E. Shope. 1995. Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J. Infect. Dis. 171:1144-1151.
67. Sutcliffe, J. G., T. M. Shinnick, N. Green, and R. A. Lerner. 1983. Antibodies that react with predetermined sites on proteins. Science 219:660-666.
68. Swofford, D. 1998. PAUP*, Phylogenetic Analysis Using Parsimony (*and Other Methods), 4 ed. Sinauer Associates, Sunderland, Mass.
69. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, A. L. Rothman, F. A. Ennis, and A. Nisalak. 1997. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176: 322-330.
70. Watts, D., K. Porter, R. Putvatana, R. Vasquez, C. Calampa, C. Hayes, and S. Halstead. Failure of secondary dengue 2 genotype I infection to cause dengue hemorrhagic fever. Submitted for publication.
71. Weber, K., and W. Konisberg. 1975. Proteins of the RNA phages, p. 51-84. In N. D. Zinder (ed.), RNA phages. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
72. Wengler, G., and E. Castle. 1986. Analysis of structural properties which possibly are characteristic for the 3′-terminal sequence of genomic RNA of flaviviruses. J. Gen. Virol. 67:1183-1188.
73. Wu, H.-N., and O. C. Uhlenbeck. 1987. Role of a bulged A residue in a specific RNA-protein interaction. Biochemistry 26:8221-8227.
74. Zhao, B., E. Mackow, A. Buckler-White, L. Markoff, R. M. Chanock, C. J. Lai, and Y. Makino. 1986. Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology 155:77-88.
75. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48-52.